Taken together, it is likely that the regulation of EGFR phosphorylation through PTPRH activation and RhoB degradation by the CUL3/KCTD10 E3 complex is conserved in HER2/EGFR-double positive breast cancer cells. Here, CUL3 is linked to breast carcinoma.